COVID-19
HHS Announces Wind-Down of mRNA Vaccine Development Activities
The U.S. Department of Health and Human Services (HHS) has announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA). This decision comes after a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.